onr:"swepub:oai:DiVA.org:uu-336838"
Search: onr:"swepub:oai:DiVA.org:uu-336838" > Treatment Trends, E...
- 1 of 1
- Previous record
- Next record
- To hitlist
Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients : a Multicenter, Retrospective Cohort Study
-
- Chen, Yundai (author)
- Chinese PLA Gen Hosp 301 Hosp, Dept Cardiol, Beijing, Peoples R China.
-
- Li, Dandan (author)
- Chinese PLA Gen Hosp 301 Hosp, Dept Hematol, Beijing, Peoples R China.
-
- Jing, Jing (author)
- Chinese PLA Gen Hosp 301 Hosp, Dept Hematol, Beijing, Peoples R China.
- show more...
- show less...
- Chinese PLA Gen Hosp 301 Hosp, Dept Cardiol, Beijing, Peoples R China Chinese PLA Gen Hosp 301 Hosp, Dept Hematol, Beijing, Peoples R China. (creator_code:org_t)
- ELSEVIER, 2017
- 2017
- English.
- In: Clinical Therapeutics. - : ELSEVIER. - 0149-2918 .- 1879-114X. ; 39:9, s. 1827-1839
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Purpose: Limited data exist on the use of statins in Chinese patients with coronary artery disease (CAD) treated with percutaneous coronary intervention (PCI). We therefore conducted this study to observe the usage trend and the effectiveness of statins on LDL-C goal attainment and other lipid parameters among PCI-treated patients.Methods: This multicenter, retrospective, observational, longitudinal cohort study was conducted in PCI-treated patients with CAD between July 1, 2011, and February 28, 2015. Primary study outcomes included statin treatment pattern after PCI and proportion of patients achieving target (LDL-C) levels 1 month after PCI and initiating statin therapy.Findings: Data were analyzed for 2708 patients (mean age, 59 [10] years; median body mass index, 25.6 [4.0] kg/m(2)). From baseline to the end of 1 month, atorvastatin and rosuvastatin were the most prescribed statins; 20 mg and 10 mg were the most prescribed doses and therefore chosen for efficacy comparisons. In patients without dose changes, LDL-C reduction with rosuvastatin 10 mg was significantly greater compared with atorvastatin 20 mg (-0.67 mmol/L [from 2.44 mmol/L to 1.77 mmol/L] vs 0.54 mmol/L [from 2.40 mmol/L to 1.86 mmol/L]; P = 0.008). However, there was no difference in HDL-C, triglyceride, or total cholesterol values between groups. Age and LDL-C levels at baseline were significantly associated with target LDL-C achievement.
Keyword
- LDL-C
- observational
- percutaneous coronary intervention
- retrospective
- statins
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Clinical Therapeutics (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Chen, Yundai
- Li, Dandan
- Jing, Jing
- Yan, Hongbing
- Liu, Jinghua
- Shen, Zhujun
- show more...
- James, Stefan K, ...
- Varenhorst, Chri ...
- show less...
- Articles in the publication
- Clinical Therape ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
